- Home
- SCPH vs TEAF Comparison
SCPH vs TEAF Comparison
Compare SCPH & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- TEAF
- Stock Information
- Founded
- SCPH 2013
- TEAF 2017
- Country
- SCPH United States
- TEAF United States
- Employees
- SCPH N/A
- TEAF N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- SCPH Health Care
- TEAF Finance
- Exchange
- SCPH Nasdaq
- TEAF Nasdaq
- Market Cap
- SCPH 173.6M
- TEAF 163.2M
- IPO Year
- SCPH 2017
- TEAF N/A
- Fundamental
- Price
- SCPH $4.85
- TEAF $12.12
- Analyst Decision
- SCPH Strong Buy
- TEAF
- Analyst Count
- SCPH 3
- TEAF 0
- Target Price
- SCPH $14.00
- TEAF N/A
- AVG Volume (30 Days)
- SCPH 322.0K
- TEAF 56.1K
- Earning Date
- SCPH 08-07-2025
- TEAF 01-01-0001
- Dividend Yield
- SCPH N/A
- TEAF 9.20%
- EPS Growth
- SCPH N/A
- TEAF N/A
- EPS
- SCPH N/A
- TEAF N/A
- Revenue
- SCPH $49,969,000.00
- TEAF N/A
- Revenue This Year
- SCPH $108.95
- TEAF N/A
- Revenue Next Year
- SCPH $73.83
- TEAF N/A
- P/E Ratio
- SCPH N/A
- TEAF N/A
- Revenue Growth
- SCPH 107.79
- TEAF N/A
- 52 Week Low
- SCPH $1.94
- TEAF $11.11
- 52 Week High
- SCPH $6.28
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- SCPH 51.56
- TEAF 52.87
- Support Level
- SCPH $4.33
- TEAF $12.04
- Resistance Level
- SCPH $4.82
- TEAF $12.25
- Average True Range (ATR)
- SCPH 0.35
- TEAF 0.11
- MACD
- SCPH -0.07
- TEAF 0.01
- Stochastic Oscillator
- SCPH 49.55
- TEAF 58.06
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.